3-O-[beta-D-2-O-sulphonylquinovopyranosyl]-quinovic acid - Compound Card

3-O-[beta-D-2-O-sulphonylquinovopyranosyl]-quinovic acid

Select a section from the left sidebar

3-O-[beta-D-2-O-sulphonylquinovopyranosyl]-quinovic acid

Structure
Zoomed Structure
  • Family: Plantae - Zygophyllaceae
  • Kingdom: Plantae
  • Class: Saponin
    • Subclass: Quinovic Acid Glycoside
Canonical Smiles CC1OC(O[C@H]2CC[C@]3([C@H](C2(C)C)CC[C@@]2([C@@H]3CC=C3[C@]2(CC[C@@]2([C@H]3[C@@H](C)[C@H](C)CC2)C(=O)O)C(=O)O)C)C)C(C(C1O)O)OS(=O)(=O)O
InChI InChI=1S/C36H56O12S/c1-18-10-15-35(30(39)40)16-17-36(31(41)42)21(25(35)19(18)2)8-9-23-33(6)13-12-24(32(4,5)22(33)11-14-34(23,36)7)47-29-28(48-49(43,44)45)27(38)26(37)20(3)46-29/h8,18-20,22-29,37-38H,9-17H2,1-7H3,(H,39,40)(H,41,42)(H,43,44,45)/t18-,19+,20?,22+,23-,24+,25+,26?,27?,28?,29?,33+,34-,35+,36-/m1/s1
InChIKey WSMJRNOZKLNLOR-QZISOCEWSA-N
Formula C36H56O12S
HBA 9
HBD 5
MW 712.9
Rotatable Bonds 6
TPSA 197.12
LogP 4.83
Number Rings 6
Number Aromatic Rings 0
Heavy Atom Count 49
Formal Charge 0
Fraction CSP3 0.89
Exact Mass 712.35
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Zygophyllum coccineum Zygophyllaceae Plantae 90540

Showing of synonyms

  • Pöllmann K, Gagel S, et al. (1997). Triterpenoid Saponins from the roots of zygophyllum Species. Phytochemistry,1997,44(3),485-9. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 712.9 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 712.9 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 712.9 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.96
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.6
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
72.16

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.71
Plasma Protein Binding
83.66
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
1.19
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-3.11
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.23
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
3.04
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-131821.14
Rat (Acute)
2.31
Rat (Chronic Oral)
2.78
Fathead Minnow
176.15
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
9843.35
Hydration Free Energy
-2.92
Log(D) at pH=7.4
0.66
Log(P)
2.7
Log S
-2.7
Log(Vapor Pressure)
-348.85
Melting Point
296.7
pKa Acid
3.97
pKa Basic
6.57

No predicted protein targets found for this compound.

Download SDF